Targeting HDAC9-BRG1-MALAT1 complex by deletion of Malat1 or Hdac9 in vivo restores contractile protein gene expression, improves aortic mural architecture, and inhibits experimental aneurysm growth in Fbn1C1039G/+ (Marfan syndrome) mouse model. Here, MALAT1 is linked to Marfan syndrome.